Loading...

LIMN LIMINATUS PHARMA INC Management Changes 8-K Filing

LMNT

LMN

LIMINATUS PHARMA INC

(LIMN)

2025 8-K

Bylaw Amendment

Stock Offering Details

Settlement Agreement

Delisting Notice

Nasdaq Non-Compliance

Nasdaq Non-Compliance

Research Update

Investor Meetings

Non-Compliance Notification

Merger of Equals

Merger of Equals

External Links:

On July 10, 2025, Liminatus Pharma, Inc. expanded its Board of Directors by adding Philip Lemons and Richard Baek, both bringing valuable expertise in clinical research and financial oversight.

AI Assistant

LIMINATUS PHARMA INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.